Core Laboratories (NYSE:CLB) Shares Down 6.7% - Time to Sell?

Key Points

• Shares fell 6.7% on Friday to $13.67 with trading volume down about 55% versus average, and the stock is trading below both its 50‑day and 200‑day moving averages (~$16.66), signaling near‑term downward momentum.
• Analysts have a consensus "Hold" rating with an average target price of $12.50, implying potential downside from current levels; Weiss Ratings reiterated a Hold (c) rating.
• Core Labs reported Q1 EPS of $0.06 (in line with estimates) with revenue down 1.4% year‑over‑year and set Q2 guidance of $0.060–$0.120; the company has a market cap of ~$650.7M, a P/E of ~21.8, and a minimal dividend yield (~0.3%).

Shares of Core Laboratories Inc. (NYSE:CLB - Get Free Report) dropped 6.7% on Friday . The company traded as low as $13.78 and last traded at $13.67. Approximately 177,203 shares traded hands during trading, a decline of 55% from the average daily volume of 396,710 shares. The stock had previously closed at $14.65.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a "hold (c)" rating on shares of Core Laboratories in a research report on Friday, March 27th. Four investment analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $12.50.

Core Laboratories Price Performance

The company has a debt-to-equity ratio of 0.41, a current ratio of 2.02 and a quick ratio of 1.51. The firm has a market cap of $650.66 million, a P/E ratio of 21.79, a PEG ratio of 3.25 and a beta of 1.15. The stock's 50-day simple moving average is $16.66 and its two-hundred day simple moving average is $16.68.

Core Laboratories (NYSE:CLB - Get Free Report) last posted its quarterly earnings data on Wednesday, April 29th. The oil and gas company reported $0.06 earnings per share for the quarter, meeting analysts' consensus estimates of $0.06. Core Laboratories had a net margin of 5.94% and a return on equity of 11.55%. During the same quarter in the previous year, the business earned $0.14 EPS. Core Laboratories's revenue for the quarter was down 1.4% on a year-over-year basis. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS. Equities research analysts forecast that Core Laboratories Inc. will post 0.57 earnings per share for the current fiscal year.

Core Laboratories Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Stockholders of record on Monday, May 11th will be paid a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend is Monday, May 11th. Core Laboratories's payout ratio is currently 6.15%.

Institutional Trading of Core Laboratories

Large investors have recently made changes to their positions in the stock. CWA Asset Management Group LLC purchased a new stake in shares of Core Laboratories during the fourth quarter valued at $9,978,000. Pacific Ridge Capital Partners LLC purchased a new stake in shares of Core Laboratories during the third quarter valued at $525,000. GAMMA Investing LLC boosted its stake in shares of Core Laboratories by 73.3% during the fourth quarter. GAMMA Investing LLC now owns 5,157 shares of the oil and gas company's stock valued at $83,000 after purchasing an additional 2,181 shares during the period. FourThought Financial Partners LLC purchased a new stake in shares of Core Laboratories during the third quarter valued at $310,000. Finally, Intech Investment Management LLC boosted its stake in shares of Core Laboratories by 6.7% during the third quarter. Intech Investment Management LLC now owns 44,504 shares of the oil and gas company's stock valued at $550,000 after purchasing an additional 2,801 shares during the period. 97.81% of the stock is owned by hedge funds and other institutional investors.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company's portfolio spans two primary service lines: reservoir description and production enhancement.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.